- Home
- A-Z Publications
- The International Journal of Gastroenterology and Hepatology Diseases
- Previous Issues
- Volume 3, Issue 1, 2024
The International Journal of Gastroenterology and Hepatology Diseases - Volume 3, Issue 1, 2024
Volume 3, Issue 1, 2024
-
-
Emerging Nanoparticle-Based Herbal Drug Delivery Systems for Colon Targeting Therapy
Authors: Dipthi Shree, Chinam Niranjan Patra and Biswa Mohan SahooHerbal medications hold a dominant position in the pharmaceutical sector due to their well-established therapeutic effects and extremely low negative effects. Besides, herbal remedies are easily available and highly economical. However, to circumvent the issue of poor bioavailability, the combinatorial strategy of incorporating herbal medicines and nanotechnology is useful. The phytoconstituents molded in novel nanocarr Read More
-
-
-
Utility of the Non-Alcoholic Fatty Liver Disease Fibrosis Score in the Evaluation of Individuals with Medically-Complicated Obesity: A Retrospective Study
Authors: Anand Nath, Timothy R. Shope, Ivanesa L. Pardo Lameda and Timothy R. KochBackgroundIndividuals with high body mass index (BMI) are at risk for chronic liver disease. Liver biopsy is a gold standard for the diagnosis of liver disease, as well as for determining the NAFLD activity score and fibrosis stage. Blood alanine aminotransferase (ALT) can support the presence of steatohepatitis, while the non-alcoholic fatty liver disease (NAFLD) fibrosis score (using clinical features and blood testing) may predict fi Read More
-
-
-
Gastrointestinal and Liver Histopathology in Confirmed SARS-CoV-2 Patients: A Case Series
Authors: Bita Geramizadeh, Maryam Yazdanparast and Hamidreza MahboobiBackground and ObjectivesThe COVID-19 pandemic, primarily affecting the respiratory system, has raised questions about its impact on the gastrointestinal (GI) system and liver. Current literature highlights a knowledge gap in understanding the intricate effects of COVID-19 on these organs. This study aims to investigate gastrointestinal and liver histopathology in confirmed SARS-CoV-2 patients.MethodologyA retrospe Read More
-
-
-
Should Routine Diagnostics Implement Gut Microbiota Analysis?
Authors: Giuseppe Guido Maria Scarlata and Ludovico AbenavoliThe gut microbiota plays a key role in human health. Dominated by the phyla Firmicutes and Bacteroidetes, its composition is highly individualized and influenced by diet, age, genetics, and the environment. The gut-liver axis highlights the bidirectional relationship between the gut and the liver, impacting metabolic homeostasis and immune regulation. Gut dysbiosis, an imbalance in the gut microflora, contributes to liver disease Read More
-
-
-
Chilaiditi Syndrome: An Incidental Finding on a Chest Radiograph in a Long-Term Ventilated Patient
Authors: Mohamed Abdelgalil, Mustafa Abbas, Radwan Mohamed Radwan and Natnael Fekadu TekleBackgroundChilaiditi syndrome is a situation with a structural impingement of the colon on the liver, leading to an elevated hemidiaphragm in the X-ray along with a gas-like appearance in the right hemithorax. It is generally a benign disease that is managed conservatively upon diagnosis. Rarely, it can be a cause of intestinal obstruction. Chilaiditi syndrome was originally named after Demetrius Chilaiditi, the Greek radiologi Read More
-
-
-
Gut Microbiota Dysbiosis in the Pathogenesis of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD)
Authors: Gh Jeelani Mir and Nissar Ul AshrafMetabolic-dysfunction-associated steatotic liver disease (MASLD), previously referred to as nonalcoholic fatty liver disease (NAFLD), affecting approximately 30% of the global population. Projections suggest that MASLD incidence may rise by up to 56% over the next decade. MASLD has become the fastest-growing cause of hepatocellular carcinoma (HCC) in the USA, France, UK, and other regions worldwide. The prevale Read More
-
-
-
Targeting to Overexpressed Receptor in Colon Cancer: A Review
Authors: Tarun Sharma, Md. Moidul Islam, Akshay Kumar Lunawat and Sarjana RaikwarColon cancer is a major global health concern characterized by complex interactions of genetic, environmental, and lifestyle factors. The “hallmarks of cancer” encompass various distinctions between cancerous and normal tissues, including vascular characteristics, making it a possible target for medication administration with specificity. The tumor microenvironment in colon cancer is a dynamic ecosystem com Read More
-
-
-
Development and In vitro Evaluation of Pantoprazole-Sustained Release Effervescent Floating Tablets for Effective Management of Ulcer
IntroductionPantoprazole is a very suitable drug for the treatment of numerous acid-related conditions in humans and mammals. Owing to its short half-life (0.9 - 1.9 h), it is ideal for sustained release formulation.MethodsThis study was aimed at developing pantoprazole gastroretentive (GR) controlled-release tablets and to determine the effects of this formulation and processing parameters on drug release and other critical Read More
-
-
-
Agile 3+ and Metabolic Dysfunction-Associated Fatty Liver Disease: Detecting Advanced Fibrosis based on Reported Liver Stiffness Measurement in FibroScan and Laboratory Findings
More LessMetabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), formerly known as Non-alcoholic fatty liver disease (NAFLD), is characterized by fat accumulation in the liver and is associated with obesity, insulin resistance, and metabolic syndrome. Early detection and intervention are crucial to prevent disease progression to advanced fibrosis, cirrhosis, and liver failure. Non-invasive tests like transient elastography (TE), the Fibro Read More
-
-
-
Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for the Management of Gastrointestinal Disorders
Gastrointestinal (GI) disorders encompassing conditions such as gastritis, peptic ulcers, and inflammatory bowel disorders are major global health concerns affecting millions worldwide. Conventional treatment options often come with undesirable side effects, prompting the search for alternative therapies. The herb's influence on digestive processes, mucosal protection, and modulation of gut microbiota shed light on Read More
-
-
-
Navigating the Gut-brain Axis: Insights into the Pathogenesis of Hepatic Encephalopathy
Authors: Victory Aghogho Emojevwe, Arman Shahriari and Hamidreza MahboobiHepatic encephalopathy is a neurological condition that affects people who have an insufficient liver function. However, its pathophysiology is yet unclear. For hepatic encephalopathy, pharmacotherapy is the primary treatment choice. Lowering ammonia levels, enhancing neurotransmitter signal transduction, and modifying gut microbiota, tackles the pathophysiology of hepatic encephalopathy. The intestinal microbiota of li Read More
-
-
-
ASGE Predictors for the Diagnosis of Choledocholithiasis: Validation in a Public Hospital of Merida, Yucatan, México
BackgroundCholedocholithiasis is defined as the presence of calculus in the biliary tract, and is one of the main complications of cholelithiasis. Its prevalence among the Mexican population is 14%.ObjectiveTo determine the validity of predictors of choledocholithiasis in patients attending the Hospital Agustin O’Horan from January 2019 to December 2020.MethodsThis was an observational, analytical, and retrospective study. It Read More
-
-
-
A Foodborne Disease “Campylobacteriosis”: Global Epidemiology, Pathogenicity, Diagnosis and Treatment
Authors: Pooja Choudhary, Aruna Punia, Sudesh Kumari, Namita Sharma, Sweety Dahiya and Anil K. ChhillarCampylobacteriosis is a foodborne disease caused by Campylobacter, which is one of the leading causative agents of bacterial gastrointestinal diseases in developed and developing countries. According to WHO, Campylobacter species infects a hundred million people yearly. The bacterium is thermotolerant, cytochrome oxidase-positive, spiral-shaped, gram-negative, and microaerophilic, by exhibiting corkscrew motility it p Read More
-
-
-
Acetaldehyde and Butyrate: Their Biological Effects on the Liver and the Gut Axis
Authors: Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh and Avinash KumarThe gut is the most accommodating environment in the human body for bacteria. The microbial community there is both dense and varied. The gut microbe forms an axis with the human liver, according to the theory of liver disease causation. The portal vein, systemic circulation, and biliary tract all provide bidirectional connections between the liver and the intestines. The liver secretes bile acid and a wide variety of bioactiv Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/ijghd
Journal
10
5
false
en
